This is an outdated version published on 2023-12-21. Read the most recent version.

Industry News (Jul 2023 to Dec 2023)

Authors

  • Viola Huang ISoOR Insight Team

DOI:

https://doi.org/10.62714/NCQI5543

Keywords:

Organoid Development, Drug Discovery, Industry Investment, Therapeutic Application, Technological Breakthrough

Abstract

This article provides an insightful overview of recent advancements and significant events in organoid research and technology. It covers the transition of HUB Organoids to a private company, the inaugural meeting of the International Society of Organoid Research in Singapore, and developments in organoid group standards at Tsinghua Changgeng Hospital. Additionally, it highlights breakthroughs in automated culture technology, major acquisitions such as Roche's purchase of Herophilus, and substantial funding rounds like Seraxis's $50 million for diabetes organoid therapy, demonstrating the dynamic growth and potential of this field.

Downloads

Published

2023-12-21 — Updated on 2023-12-21

Versions

How to Cite

[1]
Viola Huang 2023. Industry News (Jul 2023 to Dec 2023). Journal of Organoid and Bioscience. 1, 1 (Dec. 2023), 21–23. DOI:https://doi.org/10.62714/NCQI5543.

Issue

Section

Articles